Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Substance-related disorder substance related disorder,Substance-related disorder,substance-related disorder
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Substance use disorder patients
- Group 0 sample size Number of subjects in the control (unexposed) group
- 45
- Group 1 sample size Number of subjects in the case (exposed) group
- 48
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- increased
Signature 1
Source: Figure 4
Description: Differential abundance in community compositions between SUD and healthy controls
Abundance in Group 1: increased abundance in Substance use disorder patients
NCBI | Quality Control | Links |
---|---|---|
Prevotellaceae | ||
Paracoccaceae | ||
Rhodocyclaceae | ||
Alphaproteobacteria | ||
Prevotella | ||
Paracoccus | ||
Clostridium | ||
Thauera |
Revision editor(s): WikiWorks
Signature 2
Source: Figure 4
Description: Differential abundance in community compositions between SUD and healthy controls
Abundance in Group 1: decreased abundance in Substance use disorder patients
Revision editor(s): WikiWorks
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- adjusted Healthy controls
- Group 0 sample size Number of subjects in the control (unexposed) group
- 28
- Group 1 sample size Number of subjects in the case (exposed) group
- 29
Lab analysis
Statistical Analysis
- Statistical test
- Mann-Whitney (Wilcoxon)
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- Not specified
- Matched on Factors on which subjects have been matched on in a case-control study
- age
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure 5B
Description: Significantly different microbial composition between SUD and age matched healthy controls
Abundance in Group 1: increased abundance in Substance use disorder patients
NCBI | Quality Control | Links |
---|---|---|
Thauera | ||
Paracoccus | ||
Prevotella |
Revision editor(s): WikiWorks
Signature 2
Source: Figure 5B
Description: Significantly different microbial composition between SUD and age matched healthy controls
Abundance in Group 1: decreased abundance in Substance use disorder patients
NCBI | Quality Control | Links |
---|---|---|
Anaerostipes | ||
Parabacteroides | ||
Gemmiger | ||
Bilophila | ||
Streptococcus | ||
Megasphaera | ||
Fusicatenibacter |
Revision editor(s): WikiWorks